Cargando…
Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections
Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recen...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154052/ http://dx.doi.org/10.1016/j.ceh.2023.04.001 |
_version_ | 1785036047971778560 |
---|---|
author | Chen, Yifan |
author_facet | Chen, Yifan |
author_sort | Chen, Yifan |
collection | PubMed |
description | Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data. |
format | Online Article Text |
id | pubmed-10154052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Author. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101540522023-05-03 Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections Chen, Yifan Clinical eHealth Article Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data. The Author. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2023-12 2023-05-03 /pmc/articles/PMC10154052/ http://dx.doi.org/10.1016/j.ceh.2023.04.001 Text en © 2023 The Author. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Chen, Yifan Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections |
title | Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections |
title_full | Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections |
title_fullStr | Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections |
title_full_unstemmed | Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections |
title_short | Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections |
title_sort | editorials: inactivated vaccines protection against covid-19 symptomatic infections |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154052/ http://dx.doi.org/10.1016/j.ceh.2023.04.001 |
work_keys_str_mv | AT chenyifan editorialsinactivatedvaccinesprotectionagainstcovid19symptomaticinfections |